Leading the Way in Life Science Technologies

GEN Exclusives

More »


More »

For full access to this article login to GEN Select now.

August 01, 2014 (Vol. 34, No. 14)

Enzymatics Enriches NGS with AMP

Targeted Sequencing Technology Enhances Gene Mutation Identification and Discovery

  • In transforming itself from a reagents supplier to a next-generation sequencing (NGS) applications company, Enzymatics is advancing the genomics industry. While Enzymatics continues to support and expand its fast-growing core business—reagents and kits for original equipment manufacturers—it is also taking advantage of a new technology—Anchored Multiplex PCR (AMP™) chemistry. ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.